BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26901007)

  • 1. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
    Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
    AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma.
    Kanematsu M; Goshima S; Kondo H; Nishibori H; Kato H; Yokoyama R; Miyoshi T; Hoshi H; Onozuka M; Moriyama N
    J Comput Assist Tomogr; 2005; 29(2):195-201. PubMed ID: 15772536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
    Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
    Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low contrast dose protocol involving a 100 kVp tube voltage for hypervascular hepatocellular carcinoma in patients with renal dysfunction.
    Nakaura T; Nagayama Y; Kidoh M; Nakamura S; Namimoto T; Awai K; Harada K; Yamashita Y
    Jpn J Radiol; 2015 Sep; 33(9):566-76. PubMed ID: 26162707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing iodine load in hepatic CT for patients with chronic liver disease with a combination of low-tube-voltage and adaptive statistical iterative reconstruction.
    Noda Y; Kanematsu M; Goshima S; Kondo H; Watanabe H; Kawada H; Kawai N; Tanahashi Y; Miyoshi TRT; Bae KT
    Eur J Radiol; 2015 Jan; 84(1):11-18. PubMed ID: 25455414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of optimal intravenous contrast agent iodine dose for the detection of liver metastasis at 80-kVp CT.
    Goshima S; Kanematsu M; Noda Y; Kondo H; Watanabe H; Kawada H; Kawai N; Tanahashi Y; Bae KT
    Eur Radiol; 2014 Aug; 24(8):1853-9. PubMed ID: 24865696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal multi-detector row CT: effectiveness of determining contrast medium dose on basis of body surface area.
    Onishi H; Murakami T; Kim T; Hori M; Osuga K; Tatsumi M; Higashihara H; Maeda N; Tsuboyama T; Nakamoto A; Tomoda K; Tomiyama N
    Eur J Radiol; 2011 Dec; 80(3):643-7. PubMed ID: 20864283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K; Takada K; Onishi H; Hori S
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC.
    Pfeiffer D; Parakh A; Patino M; Kambadakone A; Rummeny EJ; Sahani DV
    Abdom Radiol (NY); 2018 Dec; 43(12):3317-3323. PubMed ID: 29774382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.
    Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Funama Y; Aoyama M; Asada N; Yamashita Y
    Radiat Med; 2007 Jul; 25(6):278-88. PubMed ID: 17634881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal multidetector CT in patients with varying body fat percentages: estimation of optimal contrast material dose.
    Kondo H; Kanematsu M; Goshima S; Tomita Y; Miyoshi T; Hatcho A; Moriyama N; Onozuka M; Shiratori Y; Bae KT
    Radiology; 2008 Dec; 249(3):872-7. PubMed ID: 18941161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations.
    Yagyu Y; Awai K; Inoue M; Watai R; Sano T; Hasegawa H; Nishimura Y
    AJR Am J Roentgenol; 2005 May; 184(5):1535-40. PubMed ID: 15855112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies.
    Kim KS; Lee JM; Kim SH; Kim KW; Kim SJ; Cho SH; Han JK; Choi BI
    Invest Radiol; 2010 Mar; 45(3):149-57. PubMed ID: 20142749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
    Yanaga Y; Awai K; Nakaura T; Namimoto T; Oda S; Funama Y; Yamashita Y
    AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 80-kVp CT using Iterative Reconstruction in Image Space algorithm for the detection of hypervascular hepatocellular carcinoma: phantom and initial clinical experience.
    Hur S; Lee JM; Kim SJ; Park JH; Han JK; Choi BI
    Korean J Radiol; 2012; 13(2):152-64. PubMed ID: 22438682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.